MedTrace Logo

Exposure to Hepatitis E Virus in Occitania, France

NCT06137313 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2024-05-16

No results posted yet for this study

Summary

The objective of the proposed work is to determine the seroprevalence of HEV in 2023 in a population of blood donors living in Occitania.

Compare the current frequency of anti-HEV IgG and IgM markers with that of 2011. The serological techniques used and the questionnaires will be similar

Conditions

  • Hepatitis E

Interventions

OTHER

questionnaire

completion of a questionnaire

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Jacques Izopet, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2024-10-15
Completion
2024-11-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06137313 on ClinicalTrials.gov